Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

1:20AphotoofTaylorTarantofromadetentionmemoreleasedbytheU.S.DistrictCourtfortheDistrictofColumbia.U. AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger




leisure time

author：knowledge    Page View：6134
Franklin faces
Adobe

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

advertisement

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： ASCO: AstraZeneca's hat trick, and palliative care's spotlight
Next article： After affirmative action ruling, medical educators look to 'holistic review'